Status:
COMPLETED
Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants
Lead Sponsor:
Stanford University
Conditions:
Alcohol Withdrawal Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Complicated alcohol withdrawal syndrome (AWS) increases morbidity and mortality of hospitalized, medically ill patients. The Psychosomatic Medicine Service is commonly consulted to assist in the manag...
Detailed Description
Complicated alcohol withdrawal syndrome (C-AWS) increases morbidity and mortality of hospitalized, medically ill patients. The Psychosomatic Medicine Service is commonly consulted to assist in the man...
Eligibility Criteria
Inclusion
- All the cases referred to the Psychosomatic Medicine Service for assistance with prophylactic or symptomatic management of AWS starting 8/1/2011 until 8/31/2014.
Exclusion
- Patients who through chart review were found to have been primarily suffering from delirium from causes other than AWS.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05438641
Start Date
August 1 2013
End Date
August 1 2017
Last Update
June 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Hospital and Clinics
Stanford, California, United States, 94305